ExploreWatchlistsPricing
  1. JP-listed companies
  2. TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
  3. Financials
  4. Income before tax

TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. (E25678)

Market cap
P/E ratio
Taisho Pharmaceutical Holdings develops and sells both over-the-counter and prescription medicines, along with health products, serving customers in Japan and internationally.
SummaryFinancialsDividendsHistoryWorkforce
Period EndIncome before tax (Million JPY)YoY (%)
Mar 31, 202330,444+65.35%
Mar 31, 202218,412-29.04%
Mar 31, 202125,946+3.74%
Mar 31, 202025,010-38.78%
Mar 31, 201940,851-3.06%
Mar 31, 201842,140+10.79%
Mar 31, 201738,036+3.43%
Mar 31, 201636,775-7.08%
Mar 31, 201539,576-22.77%
Mar 31, 201451,244+16.01%
Mar 31, 201344,173-4.39%
Mar 31, 201246,201

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat